Magic pill? No. But Journavx could provide opioid assist
By JEFFREY L. REYNOLDS // People in acute pain might be relieved to know that the U.S. Food and Drug Administration recently approved Journavx, a novel painkiller that aspires to…
OxyContin
Without gov’t oversight, who watches the pushers?
By TERRY LYNAM // Most people have a negative instinctive reaction to government bureaucracy and regulatory mandates, often viewed as excessively burdensome micromanagement. Many are inarguably flawed – but regulatory…